TYP CardioVas (CV) Support
Natural health product licensed in Canada
- Other names
- BestWell CardioVas (CV) Support, BestWell Healthy CardioVas (CV), TYP Healthy CardioVas
- Licence holder
- TYP Pharmaceutical Ltd.
- NPN or DIN-HM
- 80077243
- Status
- Active licence
- Licence date
- 5 May 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Pueraria montana var. lobata (Willd.) Sanjappa & Pradeep: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Oryza sativa fermenté avec Monascus pilosus Source : Monascus pilosus - Whole | 30 milligramme | Not calculated |
| Salvia miltiorrhiza Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 220 milligramme | 110 milligramme | Not calculated |
| Allium sativum Source : Bulbe Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 200 milligramme | 20 milligramme | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 440 milligramme | 220 milligramme | Not calculated |
| Pueraria montana var. lobata Source : Racine Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 220 milligramme | 110 milligramme | Not calculated |
| Panax notoginseng Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 40 milligramme | 20 milligramme | Not calculated |
| Ligusticum sinense cv. chuanxiong Source : Rhizome Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 150 milligramme | 75 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, farine de riz, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 3 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help maintain cardiovascular health in adults. Used in Herbal Medicine to help reduce elevated blood lipid levels/hyperlipidemia in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity has been known to occur; in which case discontinue use.
- Précautions et mises en garde
If you are pregnant or breastfeeding, or plan to become pregnant, do not use this product. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are taking blood thinners or protease inhibitors. Consult a health care practitioner prior to use if you have an autoimmune disorder. If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, particularly cardiovascular medications such as hydroxymethylglutaryl CoA reductase lipid - lowering drugs (statins), thyroid hormone replacement therapy, cyclosporine, or anti-diabetic drugs, consult a health care practitioner prior to use. If you suffer from liver disorder or develop liver - related symptoms (e.g., abdominal pain, jaundice, or dark urine), kidney disease, bleeding disorder, or have received an organ transplant, consult a health care practitioner prior to use. If you experience heartburn, muscle pain, tenderness and/or weakness, discontinue use and consult a health are practitioner.
Source
Official Health Canada record, licence 80077243
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.